Veterinary Drug terms — page 18 | HESTIA Glossary

Browse all 1,061 veterinary drug terms HESTIA uses to describe agricultural data — with definitions and synonyms. Free and open.

Pseudomonic acids Mupirocin
Puromycin 3'-[[(2S)-2-Amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-N,N-dimethyladenosine; Puromycin; P-638
Putrescine 1,4-Butanediamine; putrescine; 1,4-diaminobutane; 1,4-butanediamine; 110-60-1; butane-1,4-diamine; tetramethylenediamine; Butylenediamine; Putrescin; 1,4-Butylenediamine; Tetramethyldiamine; 1,4-Tetramethylenediamine; putrescina; Putreszin; Tetramethylendiamin; UNII-V10TVZ52E4; NSC 60545; BRN 0605282; CCRIS 6751; H2N(CH2)4NH2; AI3-25444; 1,4-Diamino-n-butane; EINECS 203-782-3; MFCD00008235; 1,4-Diaminobutane, 99%; CHEMBL46257; V10TVZ52E4; CHEBI:17148; KIDHWZJUCRJVML-UHFFFAOYSA-N; NSC-60545; PUT; butylene amine; HSDB 7865; tetramethylendiamine; 4-amino-butyl-amine; tetramethylene diamine; 1,4 diamino butane; 1,4-butane diamine; 1,4-diamino butane; Putrescine, free base; Spectrum_001646; 1i7c; 1i7m; Spectrum2_001935; Spectrum3_001198; Spectrum4_000237; Spectrum5_001005; Lopac-P-7505; ACMC-1BP9O; bmse000109; bmse000814; bmse000862; EC 203-782-3; BUTANE,1,4-DIAMINO; butane-1 pound not4-diamine; Lopac0_000972; BSPBio_002875; KBioGR_000933; KBioSS_002126; DivK1c_000716; SPBio_001969; .alpha.,.omega.-Butanediamine; Putrescine, analytical standard; GTPL2388; DTXSID4041107; CTK0I0210; KBio1_000716; KBio2_002126; KBio2_004694; KBio2_007262; KBio3_002375; KS-00000UIO; 1a99; NINDS_000716; EBD52608; HY-N2407; NSC60545; ZINC5828633; ANW-16171; BBL027703; BDBM50009385; s5825; SBB059998; STL372697; AKOS000119071; CCG-205052; DB01917; MCULE-3098044935; NE10565; RTR-002172; SDCCGMLS-0066929.P001; SDCCGSBI-0050945.P003; TRA0051657; IDI1_000716; NCGC00015837-01; NCGC00015837-02; NCGC00015837-03; NCGC00162302-01; BP-21408; LS-45640; NCI60_004431; SC-50226; AB1003236; TR-002172; CS-0022608; D0239; FT-0606836; ST45255380; 1,4-Diaminobutane, purum, >=98.0% (GC); C00134; C02896; P-7990; 1,4-Diaminobutane, puriss., >=99.0% (GC); 115003-EP2287167A1; 115003-EP2295399A2; 115003-EP2298728A1; 148095-EP2277878A1; 148095-EP2280005A1; 148095-EP2289884A1; Q410190; 1,4-Butanediamine; Putrescine; Tetramethylenediamine; InChI=1/C4H12N2/c5-3-1-2-4-6/h1-6H; F1791-1258; Z1245649995; A4738F6F-F1A1-4B30-BF38-866D5AC66C93; Putrescine; 4-04-00-01283 (Beilstein Handbook Reference)
Pyrazinamide 2-PYRAZINECARBOXAMIDE; pyrazinamide; pyrazinecarboxamide; 98-96-4; pyrazine-2-carboxamide; pyrazinoic acid amide; Zinamide; 2-Pyrazinecarboxamide; Aldinamide; Aldinamid; Pirazinamid; Pyrazineamide; Pyrafat; Tebrazid; Unipyranamide; FarmiziPirazimida; pyrazine carboxylamide; Eprazin; Novamid; 2-Carbamylpyrazine; Pyrazinecarboxylic acid amide; Pirazinamida; Pyrazinamidum; Tisamid; Isopas; Pirazinamide; Pyrazine carboxamide; Pezetamid; PiraldiD-50; Pirazinamide [DCIT]; MK 56; PZA; Pyrazinamidum [INN-Latin]; NCI-C01785; Pirazinamida [INN-Spanish]; C5H5N3O; D-50 (VAN); UNII-2KNI5N06TI; DRG 0124; NSC 14911; CCRIS 545; HSDB 3576; T 165; EINECS 202-717-6; BRN 0112306; 2KNI5N06TI; MLS000069730; CHEBI:45285; IPEHBUMCGVEMRF-UHFFFAOYSA-N; NSC14911; Pyrazinamide (Pyrazinoic acid amide); MFCD00006132; NSC-14911; Pyrazinamide, 99%; NCGC00015833-09; Braccopiral; Corsazinmid; Pyrazinamdie; Dipimide; Lynamide; PraziPyramide; Pyrazide; SMR000036662; Tebrazio; Zinastat; Rozide; DSSTox_CID_1215; DSSTox_RID_76014; DSSTox_GSID_21215; Pharozinamide; Rifafour; P ezetamid; CAS-98-96-4; Pyrazinamide (TN); 2-carbamyl pyrazine; Pyrazinamide [INN:BAN:JAN]; Rifafour e-200; Pyrazinoic acid am ide; SR-01000076077; pyrazinamida; Pyrizinamide; pyrazine amide; AZT + Pyrazinamide combination; Pyrazine-2-carboxylic acid amide; Pyrazinamide,(S); Pyrazinamide [USP:INN:BAN:JAN]; Prestwick_811; ACMC-20aive; 2-pyrazine carboxamide; Spectrum_000902; Opera_ID_735; Prestwick0_000514; Prestwick1_000514; Prestwick2_000514; Prestwick3_000514; Spectrum2_001305; Spectrum3_001046; Spectrum4_001186; Spectrum5_001026; Lopac-P-7136; CHEMBL614; P 7136; WLN: T6N DNJ BVZ; pyrazine-2-carboximidic acid; Lopac0_001011; SCHEMBL24102; BSPBio_000467; BSPBio_002572; KBioGR_001851; KBioSS_001382; 5-25-04-00178 (Beilstein Handbook Reference); KSC449E8F; MLS002222347; BIDD:GT0228; DivK1c_000241; SPECTRUM1500518; SPBio_001369; SPBio_002388; BPBio1_000515; EBD430; GTPL7287; ZINC2005; DTXSID9021215; 2-pyrazinecarboxylic acid amide; HMS500M03; KBio1_000241; KBio2_001382; KBio2_003950; KBio2_006518; KBio3_001792; Pyrazinamide (JP17/USP/INN); NINDS_000241; BDBM228814; HMS1569H09; HMS1920N08; HMS2092E09; HMS2096H09; HMS2235G17; HMS3259O04; HMS3263K03; HMS3371G09; HMS3655A10; HMS3713H09; KUC109577N; Pharmakon1600-01500518; ACT01761; BCP30257; HY-B0271; KS-00000B7D; KSC-27-052E; Tox21_110237; Tox21_202059; Tox21_302771; Tox21_501011; ANW-75384; BBL010592; CCG-39243; NSC757304; s1762; SBB004276; STK801661; AKOS000120280; Tox21_110237_1; CS-2260; DB00339; LP01011; LS-2053; MCULE-6846697749; NC00534; NSC-757304; Pyrazinecarboxamide, analytical standard; SDCCGSBI-0050984.P005; IDI1_000241; NCGC00015833-01; NCGC00015833-02; NCGC00015833-03; NCGC00015833-04; NCGC00015833-05; NCGC00015833-06; NCGC00015833-07; NCGC00015833-08; NCGC00015833-10; NCGC00015833-11; NCGC00015833-12; NCGC00015833-15; NCGC00015833-16; NCGC00090695-01; NCGC00090695-03; NCGC00090695-04; NCGC00090695-05; NCGC00090695-06; NCGC00090695-07; NCGC00256336-01; NCGC00259608-01; NCGC00261696-01; Pyrazinoic acid amide; pyrazinamide; PZA; AK-94813; CAS- 98-96-4; CPD000036662; SAM002554927; SC-46323; SY013550; TS-01626; SBI-0050984.P004; AB0008224; AB2000278; DB-002866; ST2413707; TR-030381; AB00052083; B2122; BB 0253141; EU-0101011; FT-0659757; P0633; ST45022155; SW196945-3; C01956; D00144; J10111; M-7421; AB00052083-16; AB00052083_17; AB00052083_18; AC-907/25014068; Q417571; SR-01000076077-1; SR-01000076077-4; SR-01000076077-6; W-100059; Z33546644; Pyrazinamide, British Pharmacopoeia (BP) Reference Standard; Pyrazinamide, European Pharmacopoeia (EP) Reference Standard; 2-Carbamylpyrazine; Aldinamid; Aldinamide; Pyrazinoic acid amide; Pezetamid; Pyrafat; Zinamide; Tebrazid; Pyrafat; Pyrazinoic acid amide; Pyrazinamide, United States Pharmacopeia (USP) Reference Standard; InChI=1/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9; Pyrazinamide, Pharmaceutical Secondary Standard; Certified Reference Material; Pyrazinamide; D-50
Pyridoxal 3-Hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridine carboxaldehyde; Pyridoxal; 5-21-13-00044 (Beilstein Handbook Reference)
Pyridoxine 5-Hydroxy-6-methyl-3,4-pyridinedimethanol; pyridoxine; 65-23-6; Pyridoxol; vitamin B6; Gravidox; Pyridoxin; Hydoxin; 3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine; Adermine; Pyridoxolum; 3,4-Pyridinedimethanol, 5-hydroxy-6-methyl-; 5-Hydroxy-6-methyl-3,4-pyridinedimethanol; 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol; Pyridoxinum; Piridossina [DCIT]; 3-Hydroxy-4,5-dimethylol-alpha-picoline; Pyridoxinum [INN-Latin]; Piridossina; Piridoxina [INN-Spanish]; Piridoxina; Pyridoxine [INN:BAN]; 2-Picoline-4,5-dimethanol, 3-hydroxy-; 2-Methyl-3-hydroxy-4,5-di(hydroxymethyl)pyridine; 2-Methyl-3-hydroxy-4,5-bis(hydroxymethyl)pyridine; 2-Methyl-4,5-bis(hydroxymethyl)-3-hydroxypyridine; CHEBI:16709; UNII-KV2JZ1BI6Z; (5-Hydroxy-6-methylpyridine-3,4-diyl)dimethanol; Infuvite Pediatric; EINECS 200-603-0; Pyridoxin hydrochloride; 4,5-Bis(hydroxymethyl)-2-methyl-3-pyridinol; 4,5-bis(hydroxymethyl)-2-methyl-pyridin-3-ol; 2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin [German]; Prestwick0_000623; Prestwick1_000623; Prestwick2_000623; Prestwick3_000623; 2-methyl-3-hydroxy-4,5-dihydroxymethylpyridine; Adermin hydrochloride; KV2JZ1BI6Z; 12001-77-3; M.V.I.-12 Lyophilized; TimTec1_000657; Oprea1_061614; BSPBio_000586; CBDivE_015627; SPBio_002805; BPBio1_000646; Pyridoxinum hydrochloricum; 2-Methyl-3-hydroxy-4,5-dihydroxymethyl-pyridin; LXNHXLLTXMVWPM-UHFFFAOYSA-N; Pyridoxine hydrogen chloride; M.V.I.-12; STK177324; DB00165; CAS-58-56-0; SMP2_000230; NCGC00016261-01; NCGC00016261-03; LS-134393; DSSTox_CID_3541; C00314; DSSTox_RID_77070; DSSTox_GSID_23541; AC-907/25014218; 2-methyl-3-hydroxy-4,5-bis(hydroxy-methyl) pyridine; Adermin; Bezatin; Pirivitol; CAS-65-23-6; NSC36225; Pyridoxine (Vit B6); SR-05000001644; NCGC00164317-01; Pridoxine; VitaminB6; Pyridoxine (INN); Beesix (Salt/Mix); nchembio.93-comp1; Becilan (Salt/Mix); Benadon (Salt/Mix); Hexobion (Salt/Mix); Vitamin B6 (TN); Pyridoxol; Vitamin B6; Pyridoxine, >=98%; Hexabetalin (Salt/Mix); Vitamin b6,hydrochloride; bmse000288; SCHEMBL3506; CHEMBL1364; BIDD:PXR0180; P5669_SIGMA; DTXSID4023541; CTK8A2302; ZINC49154; NSC36225 (HCL); Pyridoxol, Vitamin B6, Gravidox; AIDS006784; HMS2093L07; KUC106691N; Pharmakon1600-01505453; AIDS-006784; ALBB-022452; BCP27975; HY-B1328; Tox21_113644; Tox21_300365; ANW-46602; BBL005552; BDBM50103505; c1302; NSC759148; s3980; SBB065653; ZINC00049154; 3-hydroxy-2-Picoline-4,5-dimethanol; AKOS005410791; Tox21_113644_1; CCG-213453; CS-W019950; MCULE-7725975962; NSC-759148; TRA0073415; NCGC00016261-02; NCGC00016261-04; NCGC00016261-05; NCGC00016261-08; NCGC00164317-02; NCGC00254340-01; AC-14512; AK-27118; DS-11013; SC-46372; 58-56-0 (HCL); KSC-11-207-23; SBI-0206844.P001; 3-Hydroxy-4,5-dimethylol-.alpha.-picoline; DB-073595; TR-022227; AM20070169; FT-0631288; ST24022905; ST50907853; W7658; EN300-39851; 4,5-bis(hydroxymethyl)-2-methylpyridine-3-ol; D08454; M-7962; 4,5-Bis(hydroxymethyl)-2-methyl-3-pyridinol #; A835033; Q423746; Q-201646; SR-05000001644-1; SR-05000001644-3; 2-Methyl-3-oxylato-4,5-bis(hydroxymethyl)pyridinium; 2B3E07D2-E4CC-4CC5-B085-6070BA01F9F0; Z955123748; 2-methyl-3-hydroxy-4-hydroxymethyl-5-hydroxymethyl pyridine; InChI=1/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H; Adermine
Pyruvic acid 4-03-00-01505 (Beilstein Handbook Reference)
Quercetin 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; quercetin; 117-39-5; Sophoretin; Meletin; Xanthaurine; Quercetine; Quercetol; Quercitin; Quertine; 3,3',4',5,7-Pentahydroxyflavone; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one; Flavin meletin; 3,5,7,3',4'-Pentahydroxyflavone; Cyanidelonon 1522; T-Gelb bzw. grun 1; C.I. Natural Yellow 10; Quercetin content; Kvercetin; Quertin; C.I. Natural red 1; Kvercetin [Czech]; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one; Natural Yellow 10; C.I. 75670; CI Natural Yellow 10; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-; 3',4',5,7-Tetrahydroxyflavan-3-ol; C.I. Natural yellow 10 & 13; NSC 9219; CCRIS 1639; HSDB 3529; Flavone, 3,3',4',5,7-pentahydroxy-; NCI-C60106; UNII-9IKM0I5T1E; 3',4',5,7-tetrahydroxyflavon-3-ol; 3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on; Cyanidenolon 1522; CHEBI:16243; AI3-26018; NSC9219; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one; CHEMBL50; EINECS 204-187-1; BRN 0317313; 9IKM0I5T1E; CI 75670; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromen-4-one; 2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one; REFJWTPEDVJJIY-UHFFFAOYSA-N; NSC-9219; MFCD00006828; AK106169; DSSTox_CID_1218; DSSTox_RID_76017; DSSTox_GSID_21218; QUE; Q-200333; BRD9794; BRD-9794; CAS-117-39-5; NSC57655; NSC58588; NSC-57655; SR-01000076098; MixCom3_000183; C.I . natural yellow 10; Ritacetin; Quer; 4dfu; 4mra; Quercetin2H2O; KUC104418N; KUC107684N; 3,3',4,5,7-Pentahydroxyflavone; LIM-5662; LNS-5662; TNP00070; TNP00089; KSC-23-76; Quercetin_sathishkumar; KSC-10-126; Quercetin (Sophoretin); Quercetin - Sophoretin; Spectrum_000124; Tocris-1125; 3cf8; BiomolKI_000062; Maybridge1_008992; Prestwick0_000507; Prestwick1_000507; Prestwick2_000507; Prestwick3_000507; Spectrum2_000059; Spectrum3_000642; Spectrum4_000807; Spectrum5_001389; Lopac-Q-0125; P0042; C.I. natural yellow 13; BiomolKI2_000068; Enicostemma Littorale Blume; UPCMLD-DP081; Q 0125; NCIOpen2_007628; NCIOpen2_007882; BIDD:PXR0007; Lopac0_000999; SCHEMBL19723; BSPBio_000433; BSPBio_001068; BSPBio_002243; KBioGR_000408; KBioGR_001293; KBioSS_000408; KBioSS_000584; 5-18-05-00494 (Beilstein Handbook Reference); KSC497C4F; MLS006011766; BIDD:ER0315; DivK1c_000485; SCHEMBL219729; SPECTRUM1500672; CU-01000012502-3; SPBio_000217; SPBio_002354; BDBM7460; BPBio1_000477; GTPL5346; MEGxp0_000381; SGCUT00001; 3,4',5,7-Pentahydroxyflavone; DTXSID4021218; NIOSH/LK8760000; UPCMLD-DP081:001; ACon1_000560; CTK3J7142; HMS501I07; KBio1_000485; KBio2_000408; KBio2_000584; KBio2_002976; KBio2_003152; KBio2_005544; KBio2_005720; KBio3_000775; KBio3_000776; KBio3_001463; 3,7,3',4'-Pentahydroxyflavone; NINDS_000485; 3',5,7-Tetrahydroxyflavan-3-ol; 3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one; Bio1_000369; Bio1_000858; Bio1_001347; Bio2_000374; Bio2_000854; HMS1362F09; HMS1792F09; HMS1923O19; HMS1990F09; HMS3263G19; HMS3267M12; HMS3414J21; HMS3649D04; HMS3656C15; HMS3678J19; to_000078; ZINC3869685; 3,5,7,3',4'-Pentahydroxyflavon; Tox21_202308; Tox21_300285; Tox21_500999; ANW-73134; BBL005513; BS0155; CCG-40054; CQ0011; Flavone,3',4',5,7-pentahydroxy-; GP9232; LMPK12110004; LS-589; NSC 57655; NSC324608; s2391; SBB012521; STK365650; Quercetin, >=95% (HPLC), solid; 3,4',5,5',7-pentahydroxy-Flavone; AKOS000511724; CS-3981; DB04216; DS-3416; EBD2197934; LP00999; MCULE-2433372790; NUT0000107; RTX-012622; SDCCGSBI-0050972.P003; IDI1_000485; IDI1_002129; KS-0000021G; LDN 0052529; LDN-0052529; SMP1_000252; Flavone, 3,4',5,5',7-pentahydroxy-; NCGC00015870-01; NCGC00015870-02; NCGC00015870-03; NCGC00015870-05; NCGC00015870-06; NCGC00015870-07; NCGC00015870-08; NCGC00015870-09; NCGC00015870-10; NCGC00015870-11; NCGC00015870-12; NCGC00015870-13; NCGC00015870-14; NCGC00015870-15; NCGC00015870-16; NCGC00015870-17; NCGC00015870-18; NCGC00015870-19; NCGC00015870-21; NCGC00015870-22; NCGC00015870-23; NCGC00015870-24; NCGC00025016-01; NCGC00025016-02; NCGC00025016-03; NCGC00025016-04; NCGC00025016-05; NCGC00025016-06; NCGC00025016-07; NCGC00025016-08; NCGC00168962-01; NCGC00168962-02; NCGC00168962-03; NCGC00168962-04; NCGC00254218-01; NCGC00259857-01; NCGC00261684-01; 4CN-0923; 74893-81-5; AC-19596; AC-29756; HY-18085; LS-69030; NCI60_042036; S295; SC-25667; SMR000112559; ST024706; ST057237; SY057722; (+)-3,3',4',5,7-Pentahydroxyflavone; Quercetin, Sophoretin, Meletin, Quercetine; AX8030401; EU-0100999; FT-0603318; FT-0655108; LK87600000; N1841; Q0025; ST24039236; SW148203-4; Quercetin; 3,3',4',5,7-Pentahydroxyflavone; 17Q395; A-8821; C00389; K00029; S00057; WLN: T66 BO EVJ CR CQ DQ & DQ GQ IQ; Flavone, 3,3',4',5,7-pentahydroxy-, (+)-; Q409478; SR-01000076098-1; SR-01000076098-3; SR-01000076098-7; SR-01000076098-8; BRD-K97399794-001-02-1; BRD-K97399794-001-07-0; BRD-K97399794-001-09-6; BRD-K97399794-001-11-2; BRD-K97399794-335-03-1; SR-01000076098-11; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromone; hydrate; 49643640-FD4C-4B93-BD28-0D7C2021CC52; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one #; (+)-4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-; 4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-, zirconium(2+) salt (1:1); Quercetin; C.I. 75670
Quinalizarin 1,2,5,8-Tetrahydroxy-9,10-anthracenedione; quinalizarin; 1,2,5,8-Tetrahydroxyanthraquinone; Alizarinbordeaux; 81-61-8; Alizarine Bordeaux B; 1,2,5,8-tetrahydroxyanthracene-9,10-dione; Khinalizarin; Quinalizarine; Alizarine Bordeaux; 1,4,5,6-Tetrahydroxyanthraquinone; C.I. Mordant Violet 26; 1,2,5,8-Tetrahydroxy-9,10-anthraquinone; 9,10-Anthracenedione, 1,2,5,8-tetrahydroxy-; Alizarin Bordeaux BD; C.I. 58500; 1,2,5,8-Tetrahydroxy-9,10-anthracenedione; NSC 144046; 1,2,5,8-Tetrahydroxyanthracinon; UNII-6D43C3LYSG; NSC 4896; Anthraquinone, 1,2,5,8-tetrahydroxy-; CCRIS 5598; NSC4896; EINECS 201-366-6; BRN 1889617; 6D43C3LYSG; CHEMBL29898; 1,2,5,8-Tetrahydroxyanthra-9,10-quinone; CHEBI:37495; 1,2,5,8-Tetrahydroxy-Anthraquinone; 1,5,8-Tetrahydroxyanthracinon; 9, 1,2,5,8-tetrahydroxy-; 1,5,8-Tetrahydroxyanthraquinone; Anthraquinone,2,5,8-tetrahydroxy-; 1,5,8-Tetrahydroxy-9,10-anthraquinone; 1,2,5,8-Tetrahydroxy anthraquinone; Alizarinbordeux; Chinalizarin; Quinalizarin, E; TXQ; Mordant Violet 26; Spectrum_000952; 3fl5; Spectrum2_001362; Spectrum3_000778; Spectrum4_000998; Spectrum5_000846; BSPBio_002456; KBioGR_001435; KBioSS_001432; 4-08-00-03683 (Beilstein Handbook Reference); DivK1c_000144; SCHEMBL138122; SPECTRUM1500759; SPBio_001284; DTXSID4052558; CTK3E8610; HMS500H06; KBio1_000144; KBio2_001432; KBio2_004000; KBio2_006568; KBio3_001676; PHF 016; Quinalizarin, >=95% (HPLC); NINDS_000144; VBHKTXLEJZIDJF-UHFFFAOYSA-N; HMS1923K15; NSC-4896; ZINC3874832; BBL012309; BDBM50041419; CCG-38979; MFCD00001205; NSC144046; SBB056977; STK803167; AKOS004901435; DB08660; MCULE-6434498680; NSC-144046; 1, 2, 5, 8-Tetrahydroxyanthraquinone; IDI1_000144; NCGC00095268-01; NCGC00095268-02; NCGC00095268-03; CC-02789; LS-20711; NCI60_004175; VS-03274; 1,5,8,10-tetrahydroxy-2,9-anthraquinone; 2,5,8,9-tetrahydroxy-1,10-anthraquinone; 2,8,9,10-tetrahydroxy-1,5-anthraquinone; 4,5,6,9-tetrahydroxy-1,10-anthraquinone; 4,7,8,9-tetrahydroxy-1,10-anthraquinone; 4,8,9,10-tetrahydroxy-1,7-anthraquinone; 5,6,9,10-tetrahydroxy-1,4-anthraquinone; 5,8,9,10-tetrahydroxy-1,2-anthraquinone; FT-0606262; ST50993100; X6974; 1,2,5,8-Tetrahydroxyanthra-9,10-quinone #; A840172; C-17130; SR-01000196297; 1,2,5,8-tetrakis(oxidanyl)anthracene-9,10-dione; Q1073575; SR-01000196297-1; 1,2,5,8-tetrahydroxy-9,10-dihydroanthracene-9,10-dione; 1,2,5,8-Tetrahydroxy anthraquinone; C.I. 58500
Quinidine (9S)-6'-Methoxycinchonan-9-ol; quinidine; 56-54-2; (+)-Quinidine; Pitayine; beta-Quinine; (8R,9S)-Quinidine; Cin-Quin; Conchinin; Conquinine; Chinidin; Quinidex; (9S)-6'-Methoxycinchonan-9-ol; Kinidin; Conchinine; chinidinum; quinidina; Quiniduran; Chinidine; UNII-ITX08688JL; Quinaglute; Quinidine sulfate; CHEBI:28593; (S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol; alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol; Quinicardine; CHEMBL1294; ITX08688JL; Cinchonan-9-ol, 6'-methoxy-, (9S)-; 6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol; Chinidin [German]; (1S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol; QUINIDINE HYDROCHLORIDE; MFCD00135581; Auriquin; beta-Quinidine; (3'.alpha., 9S)-6'-Methoxycinchonan-9-ol; Quinidine, 98%, anhydrous; CCRIS 672; HSDB 225; TCMDC-131239; C20H24N2O2; NCI-C56246; EINECS 200-279-0; (R)-(6-methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol; (S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol; (S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol; (S)-[(4S,5R,7R)-5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl]-(6-methoxyquinolin-4-yl)methanol; SMR000857275; Quinidine [BAN:NF]; Quinindine; Quinicine; (9S)-6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol; alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol (9S)-; (8R,9S)-6'-Methoxycinchonan-9-ol; (S)-(6-methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol; (S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol; AK-57138; Quinidine, anhydrous; PubChem7994; Prestwick3_000280; bmse000511; Epitope ID:141803; SCHEMBL15943; BSPBio_000160; MLS001335913; MLS001335914; MLS002548869; BPBio1_000176; GTPL2342; DTXSID4023549; SCHEMBL17537608; BIB1110; ZX-AFC000840; HMS2234L10; HMS3259O09; ACT09863; HY-B1751; ZINC3831405; BDBM50121975; RW2069; AKOS015920101; CCG-256507; CS-7812; DB00908; MCULE-7178915526; NC00478; SDCCGMLS-0066600.P001; NCGC00091231-01; NCGC00091231-02; NCGC00091231-03; AS-30538; BR-57138; CPD000857275; SAM002264644; SC-05389; SC-88763; AX8150056; ST2413763; AB00514657; FT-0082277; 6470-EP1441224A2; 6470-EP2272835A1; 6470-EP2272844A1; 6470-EP2272972A1; 6470-EP2272973A1; 6470-EP2275411A2; 6470-EP2277872A1; 6470-EP2305655A2; 6470-EP2314576A1; 6470-EP2314585A1; M-7594; AB01562940_01; Q412496; W-109256; BRD-K59632282-052-01-5; BRD-K59632282-052-02-3; BRD-K70799801-311-02-7; Quinidine, crystallized, >=98.0% (dried material, NT); QDN; Quinidine; CCRIS 672
Quinolones Fluoroquinolones; Besifloxacin; Cinoxacin; Ciprofloxacin; Danofloxacin; Delafloxacin; Difloxacin; Enoxacin; Enrofloxacin; Fleroxacin; Flumequine; Garenoxacin; Gatifloxacin; Gemifloxacin; Grepafloxacin; Ibafloxacin; Levofloxacin; Lomefloxacin; Marbofloxacin; Moxifloxacin; Nadifloxacin; Nalidixic Acid; Norfloxacin; Ofloxacin; Orbifloxacin; Ozenoxacin; Oxolinic Acid; Pazufloxacin; Pefloxacin; Pipemidic Acid; Piromidic Acid; Pradofloxacin; Prulifloxacin; Rosoxacin; Rufloxacin; Sitafloxacin; Sparfloxacin; Temafloxacin
Quinoxalines Carbadox; Olaquindox
Ranitidine N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine; ranitidine; 66357-35-5; RaticiZANTAC; Gastrosedol; Microtid; Ptinolin; Quantor; Ranidine; Raniogas; Ranisen; Ranitiget; Rantacid; Taural; Duractin; RanitidiRanitidinum; Ulceranin; Weichilin; Xanidine; Zantadin; Achedos; Acidex; Atural; Axoban; Coralen; Ezopta; Gastrial; Istomar; Logast; Mauran; Quicran; Radinat; Randin; Raniter; Sampep; Urantac; Verlost; Vesyca; Vizerul; Weidos; Zantab; Ranin; Ratic; Ul-Pep; Zantic; Rantidine; Ranitidine HCL; Ranitidinum [INN-Latin]; Ranitidina [INN-Spanish]; Ranitidine [USAN:BAN:INN]; Ranitidine Base; (E)-ranitidine; CHEBI:8776; C13H22N4O3S; Zantac (TN); CHEMBL512; 1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-; Sostril; VMXUWOKSQNHOCA-UKTHLTGXSA-N; AH-19065; HSDB 3925; NCGC00015876-07; Biotidin; DSSTox_CID_25191; DSSTox_RID_80738; N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; DSSTox_GSID_45191; (E)-N-(2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamine; 1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-; EINECS 266-332-5; RND; Ranitidine (TN); ({5-[(2-{[(1E)-1-(methylamino)-2-nitrovinyl]amino}ethylthio)methyl](2-furyl)}m ethyl)dimethylamine; dimethyl[(5-{[(2-{[(E)-1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}furan-2-yl)methyl]amine; CAS-66357-35-5; Ranitidine (USAN/INN); Gavilast; SR-01000075288; N-[2-[[5-[(Dimethylamino)methyl]furfuryl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine; Tocris-1967; Lopac-R-101; Prestwick2_000201; Spectrum5_001189; Epitope ID:127515; Ranitidine HCL 1/2 Type; Lopac0_001073; N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine; BIDD:GT0179; SPECTRUM1501151; GTPL1234; BDBM22893; CHEBI:92246; HMS501F22; BDBM237183; HMS1921L07; HMS2092H15; Pharmakon1600-01501151; Ranitidine (Form I And Form Ii); BCP21325; ZINC1530728; Tox21_110250; Tox21_302372; CCG-39025; NSC757851; s5662; SBB006527; STK619092; AKOS005552967; Tox21_110250_1; API0004039; KS-5230; NSC-757851; SDCCGSBI-0051043.P004; IDI1_000440; NCGC00015876-01; NCGC00015876-02; NCGC00015876-03; NCGC00015876-04; NCGC00015876-05; NCGC00015876-06; NCGC00015876-08; NCGC00015876-09; NCGC00015876-11; NCGC00018108-01; NCGC00018108-02; NCGC00018108-03; NCGC00024387-02; NCGC00094913-01; NCGC00094913-02; NCGC00094913-03; NCGC00094913-04; NCGC00094913-05; NCGC00256269-01; (E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; (E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine; AC-12712; LS-67645; SC-45877; ST050299; SBI-0051043.P003; AB1009310; CAS-66357-59-3; D00422; J10378; AB00052223-10; AB00052223_11; AB00052223_12; 357R355; A835434; L000504; SR-01000075288-3; BRD-K70505054-001-02-9; Q21971328; N-[2-[[5-[(Dimethylamino)methyl]furfuryl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethylenediamine; (E)-1-N-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine; (E)-N-(2-((5-((dimethylamino)methyl)furan-2-yl)methylthio)ethyl)-N-methyl-2-nitroethene-1,1-diamine; (E)-N1'-[2-[[5-(dimethylaminomethyl)-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine; (E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine; (E)-N1'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine; 1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-, (E)-; N-[(E)-1-(Methylamino)-2-nitroethenyl]-2-[[[2-[(dimethylamino)methyl]-5-furanyl]methyl]thio]ethanamine; n-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-n'-methyl-2-nitro-1,1-ethenediamine; N-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine; N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine; Ranitidine; EINECS 266-332-5
Resveratrol 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; resveratrol; 501-36-0; trans-resveratrol; 3,4',5-Trihydroxystilbene; 3,5,4'-Trihydroxystilbene; (E)-5-(4-Hydroxystyryl)benzene-1,3-diol; (E)-resveratrol; 3,4',5-Stilbenetriol; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; Resvida; 3,4',5-Trihydroxy-trans-stilbene; SRT-501; SRT501; 3,5,4'-Trihydroxy-trans-stilbene; Resveratol; trans-3,4',5-trihydroxystilbene; 5-[(E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol; Resveratrol, natural; UNII-Q369O8926L; CHEBI:45713; C14H12O3; trans-1,2-(3,4',5-Trihydroxydiphenyl)ethylene; 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; CHEMBL165; NSC 327430; (E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzendiol; MLS000069735; 1,3-Benzenediol, 5-(2-(4-hydroxyphenyl)ethenyl)-, (E)-; LUKBXSAWLPMMSZ-OWOJBTEDSA-N; trans-3,4',5 - trihydroxystilbene; NSC327430; NSC-327430; Q369O8926L; 5-((1E)-2-(4-Hydroxyphenyl)ethenyl)-1,3-benzenediol; 1,3-Benzenediol, 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-; SMR000058206; DSSTox_CID_11980; DSSTox_RID_78898; DSSTox_GSID_31980; SRT 501; 3,4',5-trihydroxy-stilbene; SR-01000000163; (E)-5-(p-Hydroxystyryl)resorcinol; 5-[(1E)-2-(4-hydroxyphenyl)vinyl]benzene-1,3-diol; CHEBI:27881; CCRIS 8952; MFCD00133799; HSDB 7571; 3fts; 4jaz; 4qer; Resveratrol, E-; Resveratrol,(S); KUC104385N; Stilbene, 2f; TaxusChinensisiRehd; NCGC00015894-02; PREVENTION 8 (RESVERATROL); AK-39118; CAS-501-36-0; STL; Prestwick_619; Resveratrol, trans-; Resveratrol, 99%; KSC-10-164; Resveratrol, synthetic; RM-1812; trans-3,4′ ,5-Trihydroxystilbene; Opera_ID_586; Prestwick2_000508; Prestwick3_000508; Spectrum5_000552; 5-[(Z)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol; R 5010; Lopac0_001111; REGID_for_CID_6240; SCHEMBL19425; BSPBio_000435; BSPBio_001114; BSPBio_003461; MLS001055357; MLS001076538; MLS001424228; MLS002207121; MLS002222231; ARONIS24568; SPECTRUM1502223; CU-01000001503-3; BPBio1_000479; cid_445154; GTPL8741; SGCUT00007; ZINC6787; Resveratrol, analytical standard; DTXSID4031980; REGID_for_CID_445154; BDBM23926; Resveratrol, >=99% (HPLC); BBC/741; BIK9013; 2l98; BCPP000091; HMS1362H15; HMS1569F17; HMS1792H15; HMS1921N04; HMS1990H15; HMS2052I09; HMS2096F17; HMS2232A18; HMS3263O04; HMS3403H15; HMS3412O14; HMS3649A20; HMS3676O14; ACT09778; BCP01416; to_000079; ZX-AS004941; ZX-AT013797; Tox21_110257; Tox21_201374; Tox21_303376; Tox21_501111; ABP000376; AC-727; BBL028252; BIA 6-512; BIA-6-512; BS0159; CCG-38874; CR-003; GP2549; GP5884; LMPK13090005; s1396; SBB055452; STL146386; AKOS005720936; Tox21_110257_1; ACN-034773; API0000480; CS-1050; DB02709; KS-5047; LP01111; LS-2146; MCULE-5678456463; NC00349; OR46018; SB17273; SDCCGMLS-0002998.P003; SDCCGSBI-0051080.P003; IDI1_002152; NCGC00017352-05; NCGC00017352-06; NCGC00017352-07; NCGC00017352-08; NCGC00017352-09; NCGC00017352-10; NCGC00017352-11; NCGC00017352-12; NCGC00017352-13; NCGC00017352-14; NCGC00017352-15; NCGC00017352-16; NCGC00017352-17; NCGC00017352-18; NCGC00017352-19; NCGC00017352-24; NCGC00024003-00; NCGC00024003-04; NCGC00024003-05; NCGC00024003-06; NCGC00024003-07; NCGC00024003-08; NCGC00024003-09; NCGC00024003-10; NCGC00024003-11; NCGC00024003-12; NCGC00024003-13; NCGC00024003-14; NCGC00257465-01; NCGC00258925-01; NCGC00261796-01; 4CN-0696; AS-12413; BR-39118; CC-34242; CPD000058206; HY-16561; SAM001246888; SC-11924; ST057251; AB0006623; AX8004672; ST2408097; EU-0101111; FT-0082623; N1848; R0071; Resveratrol, Vetec(TM) reagent grade, 98%; SW196786-4; trans [2,5,4'-trihydroxydiphenyl] ethylene; 01R360; A10785; C03582; J10118; N88795; 5-[2-(4-hydroxyphenyl)vinyl]-1,3-benzenediol; AB00052942-29; AB00052942_31; A827984; Q407329; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzoldiol; SR-01000000163-3; SR-01000000163-4; SR-01000000163-9; 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; 5-[(E)-2-(4-Hydroxyphenyl)ethenyl]benzol-1,3-diol; 5-[(E)-2-(4-Hydroxyphenyl)vinyl]-1,3-benzenediol; 5[(E)-2-(4-Hydroxyphenyl)-vinyl]benzene 1,3-diol; BRD-K25591257-001-01-2; BRD-K80738081-001-06-2; BRD-K80738081-001-07-0; BRD-K80738081-001-09-6; BRD-K80738081-001-10-4; BRD-K80738081-001-23-7; SR-01000000163-10; SR-01000000163-11; SR-01000000163-16; (E)-1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; (E)1-(3,5-dihydroxyphenyl)-2-(4-hydroxyphenyl)ethene; 5-[(1E)-2-(4-Hydroxyphenyl)ethenyl]-1,3,benzenediol; Resveratrol, certified reference material, TraceCERT(R); 1,3-Benzenediol, 5-[(E)-2-(4-hydroxyphenyl)ethenyl]-; Resveratrol, European Pharmacopoeia (EP) Reference Standard; 533C1DA0-4104-42B5-9D32-9265F40857E4; trans-Resveratrol, United States Pharmacopeia (USP) Reference Standard; 3,4',5-Trihydroxy-trans-stilbene 5-[(1E)-2-(4-hydroxyphenyl)ethenyl]-1,3-benzenediol; (E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol(E)-5-(2-(4-hydroxyphenyl)ethenyl)-1,3-benzenediol; InChI=1/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H/b2-1; Resveratrol; NSC 327430
Retinol retinol; Vitamin A; all-trans-Retinol; 68-26-8; Vitamin A1; Alphalin; Axerophthol; Afaxin; Oleovitamin A; Chocola A; Alphasterol; Apostavit; Aquasynth; Biosterol; Epiteliol; Ophthalamin; Agiolan; Agoncal; Anatola; Myvpack; Prepalin; Testavol; Veroftal; Aoral; Apexol; Avibon; Avitol; Axerol; Dofsol; Vaflol; Vitpex; Vogan; Vitamin A alcohol; Disatabs Tabs; Lard Factor; all-trans-Retinyl alcohol; Bentavit A; Dohyfral A; Alcovit A; Anatola A; Vogan-Neu; A-Mulsal; Plivit A; Vi-Alpha; A-Vitan; Atars; trans-retinol; Vafol; all-trans-Vitamin A alcohol; Retrovitamin A; Homagenets Aoral; A-Sol; Hi-A-Vita; Sehkraft A; Vitamin A1 alcohol; all-trans-Vitamin A; A-Vi-Pel; ACON; ATAV; Vi-Dom-A; All-trans retinol; Super A; Anti-infective vitamin; Solu-A; Nio-A-Let; Vio-A; Antixerophthalmic vitamin; Del-VI-A; Vitavel A; Axerophtholum; Thalasphere; Wachstumsvitamin; Vitaminum A; Vitamine A; Vitavel-A; trans-Vitamin A alcohol; Retinolo [DCIT]; Vitamin A alcohol, all-trans-; Vitamin A1, all-trans-; Retinol, all trans-; all-trans-Vitamin A1; Retinol [INN:BAN]; 11103-57-4; Retinolum [INN-Latin]; Vitamin A Oil; Vitamin A alcohol (VAN); Vi-a; Antixerophthalmisches Vitamin; Vi-alpha; Vi-alpha; Vitamin A1 alcohol, all trans; UNII-G2SH0XKK91; .beta.-Retinol; beta-Retinol; CCRIS 5444; HSDB 815; Vitamin A1 alcohol, all-trans-; C20H30O; EINECS 200-683-7; CHEMBL986; NSC 122759; BRN 0403040; G2SH0XKK91; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; (all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol; 2,4,6,8-Nonatetraen-1-ol, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-; CHEBI:17336; FPIPGXGPPPQFEQ-OVSJKPMPSA-N; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclchexen-1-yl)-2,4,6,8-nonatetraen-1-ol; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol; NSC-122759; NCGC00017343-07; Cylasphere; Retinolo; Retinolum; all-trans-Retinol, 95%; DSSTox_CID_3556; Hydrovit A; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonate-traen-1-ol; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, (all-E)-; Alcohol 9,13-dimethyl-7-(1,1,5-trimethyl-6-cyclohexen-5-yl)-7,9,11,13-nonatetraen-15-ol; DSSTox_RID_77080; DSSTox_GSID_23556; Ro-a-vit; tROL; Q-201926; W-104683; Aquasol A Parenteral; Rovimix A 500; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetr aen-1-ol; CAS-68-26-8; SMR000112036; Retinol (Vit A); [11,12-3H]-Retinol; 9-cis,13-cis-Retinol; Vitamin A (USP); Vitamin A [Natural]; SR-01000763813; Retin-11,12-t2-ol (9CI); Tegosphere VitA; .alpha.sterol; .alpha.lin; Retinyl A; trans-Retinol acid (Vitamin A); 1rbp; Vi-.alpha.; EINECS 234-328-2; MFCD00001552; (9Z)-Retinol; PubChem18446; 1gx8; Retinol-(cellular-retinol-binding-protein); Spectrum5_000993; Spectrum5_001997; EC 200-683-7; all-trans vitamin A alcohol; SCHEMBL3112; all-trans-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol; BIDD:PXR0102; 4-06-00-04133 (Beilstein Handbook Reference); MLS001066379; MLS001074751; MLS006010008; Retinol, all-trans- (8CI); SPECTRUM1501203; GTPL4053; Vitamin A|||Retinoid analogues; ALL-TRANS RETINOL (SEE ALSO RETINOID PROJECT 1); DTXSID3023556; HMS501I08; HMS1921B04; HMS2092L13; HMS2270C05; Pharmakon1600-01501203; all-trans-Retinol; (2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-ol; BCP06593; HY-B1342; ZINC3831417; Tox21_110818; Tox21_202441; Tox21_300287; BDBM50092056; BG0050; CCG-38864; LMPR01090001; NSC122759; NSC758150; s5592; AKOS015902578; DB00162; LS-1578; NSC-758150; SDCCGMLS-0066724.P001; IDI1_000486; Retinol solution, >=95.0% (HPLC); SMP2_000102; NCGC00017343-02; NCGC00017343-03; NCGC00017343-04; NCGC00017343-05; NCGC00017343-06; NCGC00017343-08; NCGC00017343-09; NCGC00091784-01; NCGC00091784-02; NCGC00091784-03; NCGC00091784-04; NCGC00091784-05; NCGC00091784-06; NCGC00254024-01; NCGC00259990-01; AC-11701; CC-35617; CC-35618; SC-61936; SC-75819; ST057232; SBI-0051690.P002; CS-0013091; C00473; C17276; D06543; 33563-EP2272846A1; 33563-EP2277869A1; 33563-EP2277870A1; 33563-EP2281813A1; 33563-EP2284174A1; 33563-EP2292608A1; 33563-EP2301936A1; 33563-EP2311820A1; 33563-EP2374791A1; AB00052248_05; 103V574; A836068; Q424976; Retinol, >=95.0% (HPLC), ~2700 U/mg; Retinol, synthetic, >=95% (HPLC), crystalline; J-014834; J-017515; SR-01000763813-2; SR-01000763813-4; BRD-K22429181-001-06-8; BRD-K64634304-001-01-5; WLN: L6UTJ A1 B1U1Y1&U2U1Y1&U2Q C1 C1; Retinol, BioXtra, >=97.5% (HPLC), ~3100 U/mg; PHENOL,2-(AMINOMETHYL)-5-FLUORO-,HYDROCHLORIDE (1:; UNII-81G40H8B0T component FPIPGXGPPPQFEQ-OVSJKPMPSA-N; 3,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol; 2,6,8-Nonatetraen-1-ol, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-E)-; 3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol, all (E)-; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-1-nona-2,4,6,8-tetraenol; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraen-1-ol; (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraen-1-ol; (2Z,4Z,6Z,8Z)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetren-1-ol; Retinol solution, 100 mug/mL +/- 25% (Refer to COA) (Ethanol with 0.1% (w/v) BHT), ampule of 1 mL, certified reference material; Vitamin A; 4-06-00-04133 (Beilstein Handbook Reference)
Rhodamine 6G 9-[2-(Ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethylxanthylium chloride (1:1); Rhodamine 6G; C.I. 45160
Ribavirin Virazole; ribavirin; 36791-04-5; Tribavirin; Rebetol; Virazole; Copegus; ViloRibamide; Ribamidil; Ribasphere; Ribavirine; Viramid; Ribamidyl; Rebetron; Varazid; RTCA; Ribavirin Capsules; RibaviriRibavirinum; Ribavirine [INN-French]; Ribavirinum [INN-Latin]; ICN-1229; Ribavirina [INN-Spanish]; 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide; 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; DRG-0028; SCH 18908; UNII-49717AWG6K; Ribavirin (Copegus); 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide; RBV; HSDB 6513; BRN 0892462; 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-1,2,4-triazole-3-carboxamide; CHEBI:63580; 49717AWG6K; Ribavirin, 98%; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide; 1-(beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide; 1H-1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-; Rebretron; Ribovirin; Viramide; Virazid; Virazide; Ribav; DSSTox_CID_3557; EN300-59237; NSC 163039; DSSTox_RID_77081; DSSTox_GSID_23557; RTC; 1,2,4-Triazole-3-carboxamide, 1-beta-D-ribofuranosyl-; 1-(beta-D-Ribofuranosyl)-1,2,4-triazole-3-carboxamide; Cotronak; Ravanex; Ribacine; Ribavirin [USAN:INN]; NSC-163039; C-Virin; Ribasphere (TN); Virazole (TN); SMR000058315; Copegus (TN); Rebetol (TN); SR-01000076112; Ribavirine; NSC163039; Ribavirin [USAN:USP:INN:BAN]; Drug: Ribavirin; Ribavirin,(S); NCGC00015904-02; AK-49185; Ribavirin, antiviral; CAS-36791-04-5; MFCD00058564; RG-964; PubChem14187; Ro-20-9963; Spectrum_001826; Virazole (Ribavirin) Inhalation Solution; 4pb1; ribofluranosyl carboxamide; Prestwick3_000993; Spectrum3_001876; Spectrum4_001252; Spectrum5_002075; R-964; Ro 20-9963/000; R 9644; SCHEMBL3727; CHEMBL1643; Lopac0_001063; BSPBio_001085; BSPBio_003352; KBioGR_001804; KBioSS_002331; cid_37542; MLS000028486; MLS002222317; DivK1c_000782; SPECTRUM1503938; Ribavirin (JP17/USP/INN); BPBio1_001195; GTPL6842; 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide; DTXSID8023557; CTK7J7594; HMS502H04; KBio1_000782; KBio2_002328; KBio2_004896; KBio2_007464; KBio3_002854; 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide; BIB6306; IWUCXVSUMQZMFG-AFCXAGJDSA-N; NINDS_000782; HMS2090L15; HMS2094O09; HMS2098G07; HMS2232P07; HMS3263E08; HMS3715G07; Pharmakon1600-01503938; BB_NC-00567; HY-B0434; ZINC1035331; Tox21_110259; Tox21_200967; Tox21_501063; BDBM50154375; CCG-38985; NSC758650; s2504; SCH-18908; Ribavirin 100 microg/mL in Methanol; AKOS001715163; Tox21_110259_1; API0004062; CS-2540; DB00811; GS-3572; LP01063; LS-1241; MCULE-9495128592; NSC-758650; SDCCGSBI-0051033.P004; IDI1_000782; SMP1_000261; NCGC00090726-01; NCGC00090726-03; NCGC00090726-04; NCGC00090726-05; NCGC00090726-06; NCGC00090726-07; NCGC00090726-08; NCGC00090726-09; NCGC00090726-12; NCGC00258520-01; NCGC00261748-01; AS-34178; BR-49185; CC-34249; CPD000058315; SAM002548967; SC-12159; BCP0726000138; SBI-0051033.P003; AB0068936; AX8005387; ST2413783; AB00430481; EU-0101063; FT-0082885; FT-0630597; FT-0649908; R0077; D00423; J10190; M-7546; AB00430481-15; AB00430481-16; AB00430481_17; AB00430481_18; 1-beta-Ribofuranosyl-1,2,4-triazole-3-carboamide; 791R045; C-14783; Q421862; SR-01000721904; SR-01000076112-2; SR-01000076112-3; SR-01000076112-4; SR-01000721904-2; BRD-K60369935-001-02-7; BRD-K60369935-001-18-3; SR-01000076112-11; 1-?-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide; Ribavirin, British Pharmacopoeia (BP) Reference Standard; Z1522567185; 1-(beta -D-ribofuranosyl)-1,2,4-triazole-3-carboxamide; Ribavirin, European Pharmacopoeia (EP) Reference Standard; Ribavirin, United States Pharmacopeia (USP) Reference Standard; Ribavirin, Pharmaceutical Secondary Standard; Certified Reference Material; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-oxolanyl]-1,2,4-triazole-3-carboxamide; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,2,4-triazole-3-carboxamide; Ribavirin; BRN 0892462
Riboflavin (-)-Riboflavin; riboflavin; vitamin B2; Lactoflavin; Riboflavine; Vitamin G; 83-88-5; Lactoflavine; (-)-riboflavin; Beflavin; Beflavine; Flavaxin; Ribocrisina; Riboflavina; Vitaflavine; Flaxain; Lactobene; Ribipca; Riboderm; Ribosyn; Ribotone; Ribovel; Vitamin Bi; Flavin BB; Vitasan B2; Riboflavinum; HYRE; Russupteridine Yellow III; 7,8-Dimethyl-10-ribitylisoalloxazine; 6,7-Dimethyl-9-D-ribitylisoalloxazine; E101; Riboflavinequinone; Riboflavine [INN-French]; Riboflavinum [INN-Latin]; Riboflavina [INN-Spanish]; Dermadram; Fiboflavin; Hyflavin; HSDB 817; Aqua-Flave; UNII-TLM2976OFR; CCRIS 1904; CHEBI:17015; 7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine; C17H20N4O6; 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione; EINECS 201-507-1; NSC 33298; Riboflavin (Vitamin B2); TLM2976OFR; AI3-14697; Isoalloxazine, 7,8-dimethyl-10-D-ribityl-; AUNGANRZJHBGPY-SCRDCRAPSA-N; 1-deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-D-ribitol; D-Ribitol, 1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo(g)pteridin-10(2H)-yl)-; MFCD00005022; DSSTox_CID_1777; Isoalloxazine, 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-; 1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol; DSSTox_RID_76321; DSSTox_GSID_21777; 1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol; 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4(3H,10H)-dione; 7,8-dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4(3H,10H)-dione; Riboflavin (Vit B2); Benzo(g)pteridine-2,4(3H,10H)-dione, 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-; Riboflavin [USP:INN:BAN]; Riboflavin [USAN:INN:JAN]; NSC-33298; 1kyv; 2ccb; 2vxa; ()-Riboflavin; San Yellow B; CAS-83-88-5; NCGC00017291-05; Bisulase (TN); 13123-37-0; Food Yellow 15; Prestwick_442; Vitamin B2; E101; 2fl5; 2vx9; 4d1y; Prestwick3_000634; Epitope ID:161730; SCHEMBL7706; CHEMBL1534; BSPBio_000628; MLS001066391; BPBio1_000692; GTPL6578; Riboflavin (JP17/USP/INN); RIBOFLAVINE; VITAMIN B2; DTXSID8021777; BIR0613; INS NO. 101(I); ZX-AFC000568; (-)-Riboflavin, 97-103%; HMS2096P10; Benzo[g]pteridine riboflavin deriv.; HY-B0456; Riboflavin(B2); 7,8-Dimethyl-10-((2S,3S,4R)-2,3,4,5-tetrahydroxypentyl)benzo[g]pteridine-2,4(3H,10H)-dione; ZINC2036848; Tox21_110813; Tox21_111714; Tox21_201633; Tox21_302980; 6,7-Dimethyl-9-ribitylisoalloxazine; BDBM50362895; s2540; Riboflavin (B2), analytical standard; Tox21_111714_1; CS-2567; DB00140; LS-2192; NCI-0033298; NCGC00091288-01; NCGC00091288-02; NCGC00091288-03; NCGC00091288-05; NCGC00179498-01; NCGC00256408-01; NCGC00259182-01; AS-15936; R437; SMR000112236; AB0008077; AB2000637; ST2413784; R0020; (-)-Riboflavin, tested according to Ph.Eur.; C00255; D00050; Y-9791; (-)-Riboflavin, meets USP testing specifications; A840676; Q130365; (-)-Riboflavin, from Eremothecium ashbyii, >=98%; (-)-Riboflavin, acrylamide photopolymerization tested; Riboflavin, European Pharmacopoeia (EP) Reference Standard; Riboflavin, United States Pharmacopeia (USP) Reference Standard; Riboflavin, Pharmaceutical Secondary Standard; Certified Reference Material; 5-deoxy-5-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)-D-ribitol; 7,8-dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-Benzo[g]pteridine-2,4(3H,10H)-dione; Riboflavin for peak identification, European Pharmacopoeia (EP) Reference Standard; (-)-Riboflavin (Vitamin B2) solution, 100 mug/mL (Methanol:0.1% Ammonium acetate in Water (1:1)), ampule of 1 mL, analytical standard; (-)-Riboflavin, 100 mug/mL (1% ammonium acetate in 50:50 methanol:water), certified reference material, ampule of 1 mL; (-)-Riboflavin, BioReagent, suitable for cell culture, suitable for insect cell culture, >=98%; (-)-Riboflavin-13C4,15N2 (Vitamin B2-13C4,15N2) solution, 100 mug/mL (1% ammonium acetate in 50:50 methanol:water), certified reference material, ampule of 1 mL; 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-2H,3H,4H,10H-benzo[g]pteridine-2,4-dione; 7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrakis(oxidanyl)pentyl]benzo[g]pteridine-2,4-dione; InChI=1/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s; Lactoflavin; AI3-14697
Riboprine N-(3-Methyl-2-buten-1-yl)adenosine; Isopentenyladenosine; 2iPA
Ricinoleic acid (9Z,12R)-12-Hydroxy-9-octadecenoic acid; 12-Hydroxy-9-octadecenoic acid; Acide ricinoleique [French]
Rifampicin 3-[[(4-Methyl-1-piperazinyl)imino]methyl]rifamycin; Rifampin; L-5103 Lepetit
Riminofenazines Clofazimine
Rolitetracycline (4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide; Rolitetracycline; Bristacin
Ronidazole ronidazole; 7681-76-7; Ronidazol; Ridzol; Ridzol P; Ridazole; Dugro; (1-Methyl-5-nitro-1H-imidazol-2-yl)methyl carbamate; (1-Methyl-5-nitroimidazol-2-yl)methyl carbamate; Ronidazolum; Ronidazol-pharmachim; Ronidazol [INN-Spanish]; Ronidazolum [INN-Latin]; UNII-E01R4M1063; Ronidazol-pharmachim [Bulgarian]; EINECS 231-675-1; 1H-Imidazole-2-methanol, 1-methyl-5-nitro-, carbamate (ester); BRN 0886221; 1-Methyl-5-nitroimidazole-2-methanol carbamate ester; AI3-27430; MLS000028665; C6H8N4O4; E01R4M1063; 1-Methyl-5-nitro-1H-imidazole-2-methanol carbamate ester; NCGC00016685-05; Carbamidsaeure-((1-methyl-5-nitroimidazol-2-yl)methyl)ester; SMR000058887; CAS-7681-76-7; DSSTox_CID_25400; DSSTox_RID_80854; 1-Methyl-2-(carbamoyloxymethyl)-5-nitroimidazole; DSSTox_GSID_45400; MCMN; SR-01000000287; Ronidazole [USAN:BAN:INN]; Ronidazole [USAN:INN:BAN]; Ronidazole (USAN); Spectrum_001147; Opera_ID_1383; Prestwick0_001115; Prestwick1_001115; Prestwick2_001115; Prestwick3_001115; Spectrum2_001037; Spectrum3_001461; Spectrum4_000450; Spectrum5_001151; 1-Methyl-2-carbamoyloxymethyl-5-nitroimidazole; BSPBio_001250; BSPBio_002981; KBioGR_000840; KBioSS_001627; (1-methyl-5-nitro-imidazol-2-yl)methyl carbamate; 5-23-10-00553 (Beilstein Handbook Reference); DivK1c_000927; SCHEMBL635714; SPECTRUM1501154; SPBio_001253; SPBio_003115; Ronidazole, analytical standard; BPBio1_001375; CHEMBL290299; DTXSID6045400; CHEBI:94804; HMS502O09; KBio1_000927; KBio2_001627; KBio2_004195; KBio2_006763; KBio3_002481; CHEBI:141154; NINDS_000927; PQFRTXSWDXZRRS-UHFFFAOYSA-N; HMS1571O12; HMS1921L13; HMS2092H21; HMS2098O12; HMS2236G04; HMS3370P07; HMS3652I06; HMS3715O12; Imidazole-2-methanol, 1-methyl-5-nitro-, carbamate (ester); Pharmakon1600-01501154; HY-B0565; ZINC1482167; Tox21_110560; Tox21_303404; 2693AH; CCG-40249; NSC757865; Ronidazol 100 microg/mL in Methanol; AKOS016014971; Tox21_110560_1; API0004094; CS-2674; NSC-757865; IDI1_000927; KS-00001F81; NCGC00016685-01; NCGC00016685-02; NCGC00016685-03; NCGC00016685-04; NCGC00016685-06; NCGC00016685-07; NCGC00016685-11; NCGC00021749-03; NCGC00021749-04; NCGC00021749-05; NCGC00257484-01; AS-10175; LS-78760; SBI-0051664.P002; AB0109558; AX8150511; TR-024581; AB00052226; FT-0674455; S4062; ST24033521; SW197236-3; A19431; D05752; AB00052226_14; AB00052226_15; Imidazole-2-methanol, 1-methyl-5-nitro-, carbamate; Q7365706; SR-01000000287-2; SR-01000000287-3; BRD-K94266545-001-15-9; (1-Methyl-5-nitro-1H-imidazol-2-yl)methyl carbamate #; 1-methyl-5-nitro-1h-imidazole-2-methanolcarbamateester; 1H-Imidazole-2-methanol, 1-methyl-5-nitro-, carbamate; 1-methyl-5-nitro-1H-imidazole-2-methanol carbamate ester; carbamic acid (1-methyl-5-nitro-2-imidazolyl)methyl ester; 1-Methyl-5-nitro-1H-imidazole-2-methanol carbamate ester (9CI); 5-23-10-00553 (Beilstein Handbook Reference)
Roxarsone (4-Hydroxy-3-nitrophenyl)arsonic acid; 3-Nitro-4-hydroxyphenylarsonic acid; A 19603
Rubiadin 1,3-Dihydroxy-2-methyl-9,10-anthracenedione; Rubiadin; CCRIS 4533
Rulide (9E)-9-[O-[(2-Methoxyethoxy)methyl]oxime]erythromycin; Roxithromycin; BRN 4286925
Rutin 3-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; RUTIN; 153-18-4; rutoside; Phytomelin; Quercetin 3-rutinoside; Birutan; Eldrin; Rutin trihydrate; Myrticolorin; Rutabion; Venoruton; 3-Rutinosyl quercetin; Bioflavonoid; Osyritrin; Paliuroside; Tanrutin; 3-Rhamnoglucosylquercetin; Rutine; Rutozyd; Melin; Quercetin-3-rutinoside; Quercetin 3-O-rutinoside; Rutinum; Rutosido; Rutosidum; Globularicitrin; Violaquercitrin; Globulariacitrin; Rutinic acid; Birutan Forte; Birutin; Quercetin rhamnoglucosine; Vitamin P; Quercetin-3beta-rutinoside; UNII-5G06TVY3R7; Ilixanthin; Oxyritin; Rutosid; 3,3',4',5,7-Pentahydroxyflavone-3-rutinoside; Rutinion acid; Quercetin 3-O-beta-D-rutinoside; C.I. 75730; Quercitin 3-rutinoside; 5G06TVY3R7; CHEMBL226335; CHEBI:28527; Quercetin 3-rhamnoglucoside; Quercetol 3-rhamnoglucoside; IKGXIBQEEMLURG-NVPNHPEKSA-N; 2-(3,4-DIHYDROXYPHENYL)-5,7-DIHYDROXY-4-OXO-4H-CHROMEN-3-YL 6-O-(6-DEOXY-ALPHA-L-MANNOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE; 3-[[6-O-(6-Deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; 3-Rhamnoglucoside of 3,3',4',5,7-pentahydroxyflavone; NCGC00160628-01; Rutosidum [INN-Latin]; Rutosido [INN-Spanish]; DSSTox_CID_2326; Rutin, 97+%; USAF CF-5; DSSTox_RID_76549; DSSTox_GSID_22326; RUT; CCRIS 7564; Rutinoside, quercetin-3, beta-; Yunxianggan; NSC 9220; EINECS 205-814-1; BRN 0075455; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyl-tetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-chromen-4-one; 3-((6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one; CAS-153-18-4; SMR000112560; AI3-19098; Rutin [JAN:NF]; 4H-1-Benzopyran-4-one, 3-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; Neoisorutin; Flavone, 3,3',4',5,7-pentahydroxy-, 3-(O-rhamnosylglucoside); Glucopyranoside, quercetin-3 6-O-alpha-L-rhamnopyranosyl-, beta-D; Quercetin, 3-(6-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside); 3,3',4',5,5',7-Hexahydroxyflavone (6-O-alpha-L-rhamnosyl-beta-D-glucoside); Glucopyranoside, quercetin-3 6-O-(6-deoxy-alpha-L-mannopyranosyl)-, beta-D-; Quercetin, 3-(6-0-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside); romen-4-one; Rutinoside, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl; hydroxyethylrutoside; Rutin (Rutoside); Venoruton (TN); Rutoside (INN); AK160322; Rutin,(S); 207671-50-9; Rutoside [INN:JAN:NF]; beta-Quercetin-3-rutinoside; BIDD:PXR0020; SCHEMBL23243; 5-18-05-00519 (Beilstein Handbook Reference); MLS000759398; MLS001424098; BIDD:ER0377; DivK1c_000644; MEGxp0_000068; DTXSID3022326; ACon1_000075; cid_5280805; HMS502A06; KBio1_000644; RUTIN (95%); NINDS_000644; HMS2051B06; 3'4'5,7-tetOH-Flavone-3-rut; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-mannopyranoside; HY-N0148; KS-00000KD1; ZINC4096846; Quercetin 3-O-beta-delta-rutinoside; Tox21_111945; Tox21_202602; BDBM50217942; s2350; AKOS015895432; Tox21_111945_1; CCG-100999; CS-5573; DB01698; DS-9708; MCULE-7397273315; NC00249; IDI1_000644; NCGC00160628-02; NCGC00160628-03; NCGC00260150-01; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one; CPD000112560; SAM001246528; SC-17389; methyltetrahydro-2H-pyran-2-yloxy)methyl); LS-194242; LS-194514; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3; FT-0601605; R0035; C05625; D08499; J10274; AB00374708-09; tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one; Q407857; SR-01000759399; Q-201691; SR-01000759399-5; A8241DA0-6EC6-48BA-BD10-3F7BD61D42CE; BRD-K20482099-001-01-1; BRD-K20482099-001-11-0; 3,3,4,5,7-PENTAHYDROXYFLAVONE-3-RHAMNOGLUCOSIDE; 3,3',4',5,7-PENTAHYDROXYFLAVONE-3-RHAMNOGLUCOSIDE; quercetin 3-O-[alpha-L-rhamnosyl-(1->6)-beta-D-glucoside]; 1340-08-5; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-ch; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(((2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)methyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4H-chromen-4-one; 2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-1-benzopyran-3-yl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside; 4H-1-Benzopyran-4-one, 3-[[6-O-(6-deoxy-.alpha.-L-mannopyranosyl)-.beta.-D-glucopyranosyl]-oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; 4H-1-Benzopyran-4-one,3-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; 56764-99-9; 4H-1-Benzopyran-4-one, 3-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-; C.I. 75730
S-Adenosyl-L-homocysteine 5'-S-[(3S)-3-Amino-3-carboxypropyl]-5'-thioadenosine; S-Adenosylhomocysteine; S-Adenosyl-L-homocysteine
Saccharin 1,2-Benzisothiazol-3(2H)-one 1,1-dioxide; 1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide; 550 Saccharine
Salbutamol alpha1-[[(1,1-Dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol; Albuterol; Aerolin
Salicylamide 2-Hydroxybenzamide; salicylamide; 2-Hydroxybenzamide; 65-45-2; o-Hydroxybenzamide; Benzamide, 2-hydroxy-; Salicylic acid amide; 2-Carbamoylphenol; Salamide; 2-Carboxamidophenol; Flarpirina; Morsarinas; Algamon; Algiamida; Allevin; Amidosal; Andasol; Cetamide; Dolomide; Dropsprin; Eggosalil; Liquiprin; Novecyl; Panithal; Raspberin; Salamid; Saliamid; Saliamin; Salicim; Salipur; Salizell; Salymid; Serramida; Urtosal; Acket; Anamid; Oramid; Salrin; Afko-Sal; Amid-Sal; Benzamide, o-hydroxy-; Salicilamida; Salicilamide; Salicylamidum; Salizell (VAN); Benesal (VAN); Salicilamide [DCIT]; Salicilamide [Italian]; Amid kyseliny salicylove; OHB; UNII-EM8BM710ZC; NSC 3115; Salicylamidum [INN-Latin]; Salicilamida [INN-Spanish]; 2-Hydroxy-benzamide; H.P. 34; SR 4326; CCRIS 6045; HSDB 227; Salicylamide, 99%; Amid kyseliny salicylove [Czech]; Benzoic acid, 2-hydroxy-, amide; EINECS 200-609-3; MFCD00007978; BRN 0742439; EM8BM710ZC; CHEMBL27577; AI3-03454; MLS000069486; CHEBI:32114; SKZKKFZAGNVIMN-UHFFFAOYSA-N; NCGC00091414-02; SMR000046394; DSSTox_CID_1726; DSSTox_RID_76295; DSSTox_GSID_21726; CAS-65-45-2; Salicylamid; Samid; Salicylamide [INN:BAN:JAN]; hydroxy benzamide; Saliclamide,(S); dihydroxybenzalamine; 2-oxidanylbenzamide; Salicylamide [USP:INN:BAN:JAN]; Salicylamide (TN); PubChem10992; Spectrum_000946; ACMC-209nqv; Opera_ID_1684; Spectrum2_001312; Spectrum3_000564; Spectrum4_000499; Spectrum5_001032; WLN: ZVR BQ; EC 200-609-3; NCIOpen2_001127; Oprea1_069894; SCHEMBL21646; BSPBio_001948; KBioGR_001017; KBioSS_001426; 4-10-00-00169 (Beilstein Handbook Reference); KSC353S5B; DivK1c_000858; SPECTRUM1500532; Salicylamide (JAN/USP/INN); SPBio_001403; ZINC2055; DTXSID3021726; CTK2F3950; HMS502K20; KBio1_000858; KBio2_001426; KBio2_003994; KBio2_006562; KBio3_001448; NSC3115; NINDS_000858; HMS1920P14; HMS2092G15; HMS2232E07; Pharmakon1600-01500532; component of Tolagesic (Salt/Mix); HY-B0811; KS-00000H1J; NSC-3115; Tox21_111129; Tox21_201944; Tox21_302801; ANW-35045; BBL016007; BDBM50056900; CCG-39250; NSC757318; s6404; SBB058584; STK301812; AKOS000120983; Tox21_111129_1; CS-7630; DB08797; LS-1556; MCULE-5482995635; NSC-757318; RTR-022279; TRA0035157; IDI1_000858; NCGC00091414-01; NCGC00091414-03; NCGC00091414-04; NCGC00091414-05; NCGC00091414-07; NCGC00256376-01; NCGC00259493-01; AK-81394; BR-81394; DS-16216; Salicylamide, puriss., >=99.0% (T); SC-46863; SBI-0051509.P003; AB1004776; ST2410041; TR-022279; EU-0000058; FT-0659360; S0006; ST45061688; D01811; M-6078; 91096-EP2380872A1; AB00052089_12; A835120; AH-034/32461056; SR-01000721923; BENZOIC ACID,2-HYDROXY,AMIDE SALICYLAMIDE; J-509663; Q2496906; SR-01000721923-2; BRD-K81130846-001-02-6; BRD-K81130846-001-12-5; Z68590124; Salicylamide, United States Pharmacopeia (USP) Reference Standard; 2-HYDROXYBENZAMIDE (SEE ALSO:N-HYDROXYBENZAMIDE (CAS 495-18-1)); InChI=1/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10; Salicylamide, Pharmaceutical Secondary Standard; Certified Reference Material; Benzamide, 2-hydroxy-; H.P. 34
Salicylhydroxamic acid N,2-Dihydroxybenzamide; Salicylhydroxamic acid; N,2-Dihydroxybenzamide; 89-73-6; 2-Hydroxybenzohydroxamic acid; Benzamide, N,2-dihydroxy-; Salicylohydroxamic acid; SHAM; Salicylohydroximic acid; 2-Hydroxybenzhydroxamic acid; O-Hydroxybenzohydroxamic acid; C7H7NO3; 2,N-Dihydroxy-benzamide; NSC 5088; SHA; NSC 193440; Saliaylhydroxamic acid; UNII-8Q07182D0T; 2-hydroxybenzenecarbohydroxamic acid; Salicylic Hydroxamic Acid; EINECS 201-934-3; Salicylhydroxamic acid, 99%; MLS000069410; CHEMBL309339; CHEBI:45615; NSC5088; HBROZNQEVUILML-UHFFFAOYSA-N; 8Q07182D0T; Benzamide,2-dihydroxy-; SMR000059099; SalicylhydroxaMicacid; salicylhydroxamate; 1-hydroxybenzene-2-carbohydroxamic acid; N-Hydroxysalicylamide; salicyl hydroximic acid; N-Salicylhydroxamic acid; Opera_ID_592; N,2-Dihydroxybenzamide #; ACMC-209r2n; bmse000772; Oprea1_838400; KSC489O2F; MLS001076305; SCHEMBL144849; DTXSID5075365; CTK3I9722; HMS2234D15; HMS3372H11; KS-00000H1K; NSC-5088; Benzamide, N,2-dihydroxy- (9CI); ANW-39357; BDBM50015089; MFCD00002110; NSC193440; SBB043988; STK387225; ZINC18169763; AKOS000120047; AKOS004905639; AKOS005260023; DB03819; FS-3250; MCULE-1133383897; NSC-193440; RTR-032945; TRA0027245; VA11713; NCGC00018115-01; NCGC00018115-02; NCGC00018115-03; AK-48843; BR-48843; O519; SC-16418; LS-144424; TR-032945; CS-0014188; FT-0082178; FT-0602045; S0008; ST24031220; ST50115655; C11343; M-5066; Q7404461; Z57842350; InChI=1/C7H7NO3/c9-6-4-2-1-3-5(6)7(10)8-11/h1-4,9,11H,(H,8,10; Salicylhydroxamic acid
Salinomycin salinomycin; Procoxacin; Coxistac; 53003-10-4; Bio-cox; UNII-62UXS86T64; CHEBI:80025; 62UXS86T64; Salinomycine [INN-French]; Salinomycinum [INN-Latin]; Salinomicina [INN-Spanish]; K 364; HSDB 7032; SalinomiciSalinomycine; Salinomycinum; AHR 3096; EINECS 258-290-1; (2R)-2-[(2R,5S,6R)-6-[(2S,3S,4S,6R)-6-[(2S,5S,7R,9S,10S,12R,15R)-2-[(2R,5R,6S)-5-ethyl-5-hydroxy-6-methyloxan-2-yl]-15-hydroxy-2,10,12-trimethyl-1,6,8-trioxadispiro[4.1.5?.3?]pentadec-13-en-9-yl]-3-hydroxy-4-methyl-5-oxooctan-2-yl]-5-methyloxan-2-yl]butanoic acid; Salinomycin [INN:BAN]; Salinomycin (Procoxacin); Procoxacin (TN); Salinomycin (INN); SCHEMBL36890; CHEMBL1208572; DTXSID4048486; KQXDHUJYNAXLNZ-XQSDOZFQSA-N; s2352; s8129; ZINC85540254; Salinomycin (from Streptomyces albus); CCG-208535; CS-1299; DB11544; E716; HY-15597; C15690; D08502; W-6068; Q411909; J-524236; SR-05000002207-3; Salinomycin, from Streptomyces albus, >=98% (HPLC); Salinomycin, Ready Made Solution, from Streptomyces albus, >=98% (HPLC); Coxistac
Salirasib 2-[[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl]thio]benzoic acid; Farnesylthiosalicylic acid; Salirasib
Salsalate 2-Hydroxybenzoic acid, 2-Carboxyphenyl ester; Salicylsalicylic acid; 4-10-00-00165 (Beilstein Handbook Reference)
Sarcosine N-Methylglycine; sarcosine; N-methylglycine; 107-97-1; Sarcosinic acid; Methylglycine; Glycine, N-methyl-; Methylaminoacetic acid; 2-(methylamino)acetic acid; N-Methylaminoacetic acid; Sarcosin; (Methylamino)acetic acid; (Methylamino)ethanoic acid; H-Sar-OH; Sargosine hydrochloride; N-Methyl glycine; Acetic acid, (methylamino)-; Cocoylsarcosine; Polysarcosine; N-methyl-Glycine; MFCD00004279; UNII-Z711V88R5F; BRN 1699442; Sarcosine, 98%; AI3-15410; Methylamino-Acetic Acid; EINECS 203-538-6; SAR; CHEMBL304383; CHEBI:15611; FSYKKLYZXJSNPZ-UHFFFAOYSA-N; Z711V88R5F; N-Methylglycocoll; (methylamino)acetate; 25951-24-0; 2-Methylaminoethanoic acid; Cocobetaine; Cocoyl sarcosine; SMR000857358; N-Cocoyl-N-methylglycine; methyl-glycine; Glycine, N-methyl-, N-coco acyl derivs.; L-sarcosine; MeGly; N-Cocoyl sarcosine; N-Methyl-glycocoll; Sarcosine, BioXtra; EINECS 270-156-4; N-Methylaminoacetate; Me-Gly-OH; MeNHCH2COOH; (methylamino)-Acetate; NSC 118114; (Methylamino)ethanoate; 68411-97-2; PubChem10995; CH3NHCH2COOH; CH3NHCH2CO2H; (methylamino)-Acetic acid; N-Cocoyl-N-methyl glycine; ACMC-2098yg; bmse000160; KSC491M6H; MLS001335909; MLS001335910; GTPL4713; DTXSID1047025; CTK3J1663; Glycine, N-methyl-, homopolymer; Sarcosine, >=99.0% (NT); HMS2231J19; ACT04970; KS-00000A8M; STR01554; ZINC4658561; ANW-15878; BBL009707; BDBM50017225; HTS000645; NSC118114; s4702; STL141072; N-Methylglycine, N-coco acyl derivs.; AKOS000120139; CS-W018511; DB12519; MCULE-4484444573; NSC-118114; RTR-001889; N-Methyl-N-(1-oxococonut alkyl)glycine; TRA-0203054; AK-47434; BP-12554; BR-47434; Sarcosine, crystallized, >=98.0% (T); SC-10425; SY001630; Sarcosine, Vetec(TM) reagent grade, 98%; HY-101037; LS-144559; TR-001889; AM20080021; B7239; FT-0659819; Glycine, N-methyl-N-(1-oxococonut alkyl)-; M0332; ST24033312; C00213; M-5949; 33780-EP2272972A1; 33780-EP2272973A1; 33780-EP2277872A1; 33780-EP2295055A2; 33780-EP2298746A1; 33780-EP2308812A2; 33780-EP2308838A1; 33780-EP2311453A1; 97113-EP2301940A1; 97113-EP2305660A1; 107S971; Q414157; W-108729; F0001-0147; Z1259161985; 484652ED-E55A-4308-8F42-0903E08DBAF4; InChI=1/C3H7NO2/c1-4-2-3(5)6/h4H,2H2,1H3,(H,5,6; 118685-91-9; 134767-26-3; Sarcosine; 4-04-00-02363 (Beilstein Handbook Reference)
Scopolamine butylbromide (1alpha,2beta,4beta,5alpha,7beta)-9-Butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide (1:1).; Butylscopolammonium bromide; Amisepan
Scyllitol Scyllo-inositol; myo-inositol; inositol; Scyllo-inositol; Muco-Inositol; epi-Inositol; i-Inositol; Allo-inositol; meso-Inositol; 87-89-8; 1D-Chiro-inositol; 1L-Chiro-inositol; 488-59-5; 643-12-9; Myoinositol; Scyllitol; cis-Inositol; D-chiro-Inositol; D-(+)-chiro-Inositol; Meat sugar; mesoinositol; Neo-inositol; 6917-35-7; cyclohexane-1,2,3,4,5,6-hexol; Myoinosite; Quercinitol; Dambose; Cyclohexane-1,2,3,4,5,6-hexaol; Cocositol; Inositene; InositiPhaseomannite; Phaseomannitol; Inosital; Iso-inositol; Cyclohexitol; 551-72-4; Mesoinosit; Mesoinosite; Scyllite; Inosite; Mesovit; Nucite; Mesol; 488-58-4; L-chiro-Inositol; chiro-inositol; Cyclohexanehexol; Inositol, meso-; Inositol, myo-; Hexahydroxycyclohexane; D-myo-Inositol; cis-1,2,3,5-trans-4,6-Cyclohexanehexol; Bios I; Insitolum; Isoinositol; (-)-Inositol; 41546-34-3; 643-10-7; d-Inositol; L-Inositol; L-myo-Inositol; Inositol, i-; Inositol (VAN); 488-55-1; D-chiro Inositol; Inositol, allo-; Inositol, muco-; L-(-)-chiro-Inositol; 1D-myo-Inositol; 1L-myo-Inositol; (+)-Inositol; 1,2,3,4,5,6-Cyclohexanehexol; Rat antispectacled eye factor; Levoinositol; CCRIS 6745; AZD 103; Inositol, epi-; Inositol, scyllo-; UNII-63GQX5QW03; UNII-8LQ63P85IC; UNII-9O6Y5O4P9W; UNII-R1Y9F3N15A; 1,2,3,5-trans-4,6-Cyclohexanehexol, cis-; MFCD00077932; ELND005; 1,3,5/2,4,6-Hexahydroxycyclohexane; UNII-4661D3JP8D; UNII-6R79WV4R10; (1R,2R,3R,4R,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexaol; (1R,2R,3S,4S,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol; 1-L-chiro-Inositol; (-)-chiro-Inositol; UNII-1VS4X81277; CHEBI:17268; AI3-16111; NSC8101; 1,3,5/2,4,6-cyclohexanehexol; UNII-4L6452S749; UNII-587A93P465; 1,2,3,5/4,6-Cyclohexanehexol; NSC 8101; (1r,2r,3r,4r,5r,6r)-cyclohexane-1,2,3,4,5,6-hexol; EINECS 201-781-2; (1R,2R,3R,4S,5S,6s)-cyclohexane-1,2,3,4,5,6-hexaol; (1R,2R,3S,4R,5r,6S)-cyclohexane-1,2,3,4,5,6-hexaol; (1R,2R,3S,4S,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexaol; 1,2,3,4,5,6-HEXAHYDROXY-CYCLOHEXANE; NSC404118; Inositol, myo- (8CI); 576-63-6; 1,2,3,4,5,6-Hexahydroxycyclohexane; NSC 404118; 63GQX5QW03; 8LQ63P85IC; 9O6Y5O4P9W; R1Y9F3N15A; 488-54-0; MI; CHEBI:10642; CHEBI:23927; CHEBI:27372; CHEBI:27987; CDAISMWEOUEBRE-CDRYSYESSA-N; CDAISMWEOUEBRE-UHFFFAOYSA-N; 4661D3JP8D; 6R79WV4R10; Inositol (VAN8C; NSC-8101; NSC45517; NSC55551; NSC55552; NSC-25142; NSC-55551; UNII-M94176HJ2F; 1VS4X81277; NSC-404118; INS; Inositol, 98+%; (1s,2s,3s,4s,5s,6s)-cyclohexane-1,2,3,4,5,6-hexol; NCGC00159409-02; (1r,2R,3S,4r,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol; (1r,2R,3S,4s,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol; (1s,2R,3R,4s,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol; cis-1,2,4-trans-3,5,6-Cyclohexanehexol; 4L6452S749; 587A93P465; DSSTox_CID_3146; DSSTox_RID_76890; DSSTox_GSID_23146; 38876-99-2; 1,3,4,5,6-Cyclohexanehexol; 1,3,5/4,6-Cyclohexanehexol; alloinositol; neoinositol; (1R,2R,3R,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol; (1r,2R,3R,4s,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol; 1,2,4/3,5,6-cyclohexanehexol; Mouse antialopecia factor; 1,2,3,4,5,6-Cyclohexanehexol #; cis-1,2,3,4,5,6-cyclohexanehexol; Inositol, cis-; Inositol, neo-; CAS-87-89-8; cis-1,3,5-trans-4,6-Cyclohexanehexol; SMR000857145; SMR000857319; SMR000857320; M94176HJ2F; Inositol NF 12; SR-05000001655; Chiro-inositol, (-)-; inositols; Matezodambose; Inositol [Nonspecific isomer]; Muscle sugar; ELND 005; inositol myo-; Inositol FCC; 4irx; Inositol, chiro-; rac-chiro-inositol; Inosital (TN); CBU; Inositol (USAN); EINECS 207-681-5; EINECS 207-682-0; EINECS 209-000-7; EINECS 211-393-5; EINECS 211-394-0; EINECS 230-024-9; MFCD00065455; NSC 25142; EPIINOSITOL; (+)-Epi-Inositol; (+)-Chiro-Inositol; Epi-inositol, 98%; allo-Inositol, 97%; Inositol [USAN:NF]; INOSITOL, MESO; Spectrum_001595; 2os9; orthorhombic myo-inositol; D-(+)-Chiro Inositol; J101.890F; J101.891D; Chiro-inositol, (+)-; INOSITOL (D); INOSITOL (L); Spectrum3_001053; Spectrum4_001193; Spectrum5_000961; myo-Inositol, >=99%; bmse000102; bmse000103; bmse000113; bmse000901; bmse000922; Epitope ID:144993; scyllo-Inositol, >=98%; SCHEMBL5831; SCHEMBL5832; SCHEMBL5969; NCIOpen2_008191; BSPBio_002606; KBioGR_001885; KBioSS_002075; KSC225S4P; MLS001332377; MLS001332378; MLS001335965; MLS001335966; MLS001335967; MLS001335968; SCHEMBL187278; SCHEMBL187397; SCHEMBL187796; SCHEMBL188106; SCHEMBL188237; SCHEMBL491333; SCHEMBL959404; SCHEMBL959405; CHEMBL122705; CHEMBL278373; CHEMBL468154; ELND-005; GTPL4495; GTPL4645; GTPL4648; GTPL4649; MEGxp0_001817; SCHEMBL1055883; SCHEMBL4748543; SCHEMBL6378921; SCHEMBL6468882; SCHEMBL6791918; CHEMBL1222251; CHEMBL1231671; CHEMBL1950780; CHEMBL3976780; DTXSID7023146; SCHEMBL12371461; SCHEMBL12377889; SCHEMBL12411898; SCHEMBL12711208; SCHEMBL12735687; SCHEMBL13058696; SCHEMBL13114115; SCHEMBL13114116; SCHEMBL13114128; SCHEMBL13207905; SCHEMBL13580047; SCHEMBL14542470; SCHEMBL21388397; ACon1_002457; CHEBI:22357; CHEBI:23311; CHEBI:24848; CHEBI:25492; CHEBI:27374; CTK1C5947; CTK8B3795; D-(+)-chiro-Inositol, 95%; KBio2_002075; KBio2_004643; KBio2_007211; KBio3_001826; L-(-)-chiro-Inositol, 95%; AZD-103; DTXSID30110000; DTXSID50905091; DTXSID60903982; myo-Inositol, p.a., 98.0%; CDAISMWEOUEBRE-GNIYUCBRSA-N; CDAISMWEOUEBRE-GPIVLXJGSA-N; CDAISMWEOUEBRE-LOLGQZEGSA-N; CDAISMWEOUEBRE-NIPYSYMMSA-N; CDAISMWEOUEBRE-OQYPVSDDSA-N; 1,2,3,4,5/6-cyclohexanehexol; 1,2,3,4/5,6-cyclohexanehexol; 1,2,3/4,5,6-cyclohexanehexol; 1,2,4,5/3,6-cyclohexanehexol; HMS2091N13; HMS2230N03; HMS2235H05; HMS2235M23; HMS3369B06; HMS3369F20; HMS3373E05; Pharmakon1600-01500352; 1,2,3,4,5,6-Cyclohexanehexaol; BCP25172; HY-B1411; HY-N3021; KS-00000QA9; KS-000017FC; NSC25142; NSC55558; ZINC1530357; Tox21_111642; Tox21_302035; 6643AB; ANW-43204; CC-093; CCG-36096; cis-Inositol, >=98.0% (TLC); KM0846; MFCD00272608; NSC-45517; NSC-55552; NSC-55558; NSC103959; NSC127230; NSC757076; s4530; STL453612; epi-Inositol, >=98.0% (HPLC); 1,2,3,4,5,6/0-cyclohexanetetrol; AKOS006240678; AKOS006332036; AKOS015895894; AKOS015912905; AKOS015912934; AKOS015960429; AKOS015960633; AKOS015994742; AKOS024318869; Tox21_111642_1; ZINC100018867; ZINC100019018; ZINC100024490; ZINC100032893; ZINC100035580; ZINC100037751; ZINC100055570; ZINC100073149; ZINC100513675; ZINC101185827; ZINC102201844; ZINC103574430; ZINC103574467; ZINC103574475; ZINC250615063; ZINC253837650; ZINC306121118; CS-4782; CS-W010757; DB03106; DB13178; DB15350; FCH1118762; HY-W010041; KS-1284; KS-1420; LS-2350; MCULE-2727773046; NSC-103959; NSC-127230; NSC-757076; TRA0065469; VC30505; KS-0000146H; TRA-0204644; D-chiro-Inositol, >=98.0% (HPLC); NCGC00159409-03; NCGC00159409-04; NCGC00169828-01; NCGC00178580-01; NCGC00178580-03; NCGC00255362-01; AC-11070; AK102790; AK546883; AS-10616; AS-68396; AS-68424; cyclohexane-1R,2R,3S,4S,5R,6S-hexol; K572; NCI60_041778; SC-18136; SC-91157; SY060836; myo-Inositol, purum, >=98.0% (HPLC); rac-chiro-1,2,3,4,5,6-cyclohexanehexol; SBI-0051369.P003; AB0014290; AX8234329; DB-051583; DB-051584; DB-054642; myo-Inositol, for microbiology, >=99.0%; TR-016439; TR-017741; TR-019452; TR-022051; TR-022053; 4CH-024633; CS-0023004; FT-0627237; FT-0632208; FT-0632209; FT-0632730; FT-0652045; FT-0670357; FT-0693444; FT-0693614; I0040; I0628; I0629; I0630; I0631; I0632; I0633; S6176; ST24024704; ST24049158; ST50406013; KS-00001292; KS-00001315; myo-Inositol, BioUltra, >=99.5% (HPLC); myo-Inositol, SAJ special grade, >=99.0%; myo-Inositol, Vetec(TM) reagent grade, 99%; 3635-EP2275412A1; 3635-EP2280282A1; 3635-EP2289886A1; 3635-EP2292088A1; 3635-EP2295417A1; 3635-EP2295437A1; 3635-EP2298312A1; 3635-EP2298775A1; 3635-EP2305636A1; 3635-EP2305677A1; 3635-EP2305682A1; 3635-EP2308879A1; C00137; C06151; C06152; C06153; C19891; D08079; I-6500; K-9876; M01914; 12513-EP2277880A1; 12513-EP2277881A1; 12513-EP2292597A1; 12513-EP2292610A1; 12513-EP2298744A2; 12513-EP2298768A1; 12513-EP2305825A1; 12513-EP2316831A1; 12513-EP2374790A1; 13719-EP2269977A2; 13719-EP2280010A2; 13719-EP2289891A2; 13719-EP2295437A1; 13719-EP2298734A2; 13719-EP2298775A1; 13719-EP2308875A1; 13719-EP2311831A1; 13719-EP2316836A1; 40032-EP2298312A1; 40032-EP2311830A1; AB00051982_13; 643C129; A834712; A836375; Q407997; Q743661; Q-201583; Q2838375; Q2974313; Q3011024; Q3023527; Q3205874; Q3331426; Q3347078; Q3589114; SR-05000001655-1; SR-05000001655-5; W-202861; W-202862; W-203081; W-203168; W-203392; 1,2,4/3,5,6-Cyclohexane-1,2,3,4,5,6-hexol; 7B0CEF84-D9CE-4A88-AA7D-EC50C89387A5; 1D7A27BF-6060-4FA9-AC46-3BD18DBA406E; 220128F1-89BF-442D-AD6D-E6D1EA7BA625; (1r,2r,3r,4r,5r,6r)-cyclohexane-1,2,3,4,5,6-hexaol; (1R,2S,3r,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexol; D-MYO-INOSITOL-1,2,5,6-TETRAPHOSPHATE SODIUM SALT; UNII-M94176HJ2F component CDAISMWEOUEBRE-LKPKBOIGSA-N; UNII-M94176HJ2F component CDAISMWEOUEBRE-SHFUYGGZSA-N; (1R,2R,3S,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexaol; (1R,2R,3S,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol; Inositol, United States Pharmacopeia (USP) Reference Standard; myo-Inositol, European Pharmacopoeia (EP) Reference Standard; (1R,2R,3S,4S,5S,6R)-CYCLOHEXANE-1,2,3,4,5,6-HEXOL; 1,2,3,4,5,6-Cyclohexanehexol, (cis,cis,cis,trans,cis,trans)- #; 1,2,3,4,5,6-cyclohexanehexol, (1alpha,2alpha,3alpha,4beta,5alpha,6beta); Inositol, Pharmaceutical Secondary Standard; Certified Reference Material; 2H3; myo-Inositol, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture; myo-Inositol, PharmaGrade, meets FCC testing specifications, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production.; Scyllitol; Quercinitol
Se-methylselenocysteine 3-(Methylseleno)-L-alanine; Se-methylselenocysteine; 26046-90-2; Methylselenocysteine; 3-(Methylseleno)-L-alanine; Se-Methyl-L-selenocysteine; Selenium-methylselenocystine; (R)-2-Amino-3-(methylselanyl)propanoic acid; Se-Methyl-seleno-L-cysteine; L-Alanine, 3-(methylseleno)-; UNII-TWK220499Z; CCRIS 5465; Se-Methyl-selenocysteine; L-Se-methylselenocysteine; C4H9NO2Se; CHEBI:27812; TWK220499Z; Se-methylseleno-L-cysteine; Se-(Methyl)selenocysteine hydrochloride; (2R)-2-amino-3-methylselanylpropanoic acid; Se-methylseleno-L-cysteine, 98%; Selenomethyl selenocysteine; Methylseleno-L-cysteine; 2574-71-2; SeMC; L-methylselenocysteine; selenomethylselenocysteine, (L)-isomer; Methylseleno-L-cystein; methyl-L-selenocysteine; Cysteine, seleno-methyl-; Lopac0_000799; 3-(Methylselanyl)-L-alanine; CHEMBL62382; SCHEMBL420015; CTK8C0517; L-Selenomethylcysteine 0.5% Tr; XDSSPSLGNGIIHP-VKHMYHEASA-N; 2218AB; ANW-64816; AKOS016005152; 2-Amino-3-methylselenyl propionic acid; CCG-204883; DB12697; SDCCGSBI-0050776.P002; ACM26046902; NCGC00162258-01; NCGC00162258-02; AX8234954; HY-114245; LS-174125; TX-017960; CS-0080570; FT-0687331; (2R)-2-amino-3-(methylselanyl)propanoic acid; C05689; 046S902; J-016235; Q21099600; 06E70014-448A-45CD-9AF1-4C0B9CF51C14; Methylselenocysteine; CCRIS 5465
Sertaconazole 1-[2-[(7-Chlorobenzo[b]thien-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole; Sertaconazole; BRN 5385663
Sertraline (1S,4S)-4-(3,4-Dichlorphenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine; Sertraline; BRN 5753709
Sertraline hydrochloride (1S,4S)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine hydrochloride (1:1); Sertraline hydrochloride [USAN:USP]; Sertraline hydrochloride
Sevoflurane 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane; sevoflurane; 28523-86-6; Sevofluran; Ultane; 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane; Sojourn; MR6S4; Sevofluranum; Sevoflurano; Sevofluranum [INN-Latin]; Sevoflurano [INN-Spanish]; Bax 3084; Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether; fluoromethyl hexafluoroisopropyl ether; UNII-38LVP0K73A; Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-; Sevorane; BRN 2041023; C4H3F7O; 38LVP0K73A; CHEBI:9130; MR-6S4; Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether; DFEYYRMXOJXZRJ-UHFFFAOYSA-N; MFCD00153189; Propane,1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-; NCGC00167421-01; Sevofrane; Petrem; ETHER, FLUOROMETHYL 2,2,2-TRIFLUORO-1-(TRIFLUOROMETHYL)ETHYL-; Ultane (TN); Sevoflurane [USAN:INN:BAN:JAN]; HSDB 8059; Sevoflurane [USAN:USP:INN:BAN:JAN]; fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether; 1H,1H,3H-Perfluoro(3-methyl-2-oxabutane); F0691; (CF3)2CHOCH2F; DSSTox_CID_26614; DSSTox_RID_81767; DSSTox_GSID_46614; SCHEMBL61918; GTPL7296; CHEMBL1200694; DTXSID8046614; CTK4G1651; Sevoflurane (JP17/USAN/INN); HMS3264N21; Pharmakon1600-01503680; ZINC1530810; Tox21_112425; ANW-42890; CS0059; NSC760367; SBB092545; AKOS007930500; CCG-213707; DB01236; NSC-760367; RTR-012574; KS-000012Q2; NCGC00167421-02; AC-15484; AS-13261; H752; LS-67851; SC-80759; AB1010907; CAS-28523-86-6; DB-047409; TR-012574; FT-0605909; C07520; D00547; K-7075; AB01563174_01; 523F866; A819479; Fluoromethyl1,1,1,3,3,3-HexafluoroisopropylEther; Q419394; SR-01000944968; J-524240; SR-01000944968-1; 1,1,1,3,3,3-hexakis(fluoranyl)-2-(fluoranylmethoxy)propane; 2,2,2-trifluoro-1-(fluoromethoxy)-1-(trifluoromethyl)ethane; Sevoflurane; BRN 2041023
Silver iodide Colloidal silver iodide
Simvastatin 2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester; Simvastatin; L 644128-000U
Sinapic acid 3-(4-Hydroxy-3,5-dimethoxyphenyl)-2-propenoic acid; Sinapinic acid; EINECS 208-487-3
Sirolimus Rapamycin; (-)-Rapamycin; 53123-88-9; AY 22989; AY-22989; I 2190A; I-2190A; I2190A; NSC 226080; RAPA; Rapammune; Rapamune; Rapamycin; SIIA 9268A; Sirolimus; Wy 090217; Rapamycin (Sirolimus); WY-090217; Antibiotic AY 22989; UNII-W36ZG6FT64; CCRIS 9024; CHEBI:9168; SILA 9268A; W36ZG6FT64; HSDB 7284; C51H79NO13; DE-109; NCGC00021305-05; DSSTox_CID_3582; DSSTox_RID_77091; DSSTox_GSID_23582; Supralimus; (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone; CAS-53123-88-9; sirolimusum; Perceiva; Cypher; NSC226080; 1fkb; 1pbk; NSC-226080; NCGC00181146-01; LCP-Siro; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl]-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone; RAP; S1039; PubChem16645; Sirolimus (RAPAMUNE); BiomolKI2_000084; Rapamycin C-7, analog 4; SCHEMBL3463; Rapamycin,Sirolimus,Rapamune; BIDD:PXR0165; 23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine; MLS006010168; Sirolimus [USAN:BAN:INN]; Sirolimus [USAN:INN:BAN]; GTPL6031; DTXSID5023582; BDBM36609; L04AA10; MS-R001; SYN1185; QFJCIRLUMZQUOT-HPLJOQBZSA-N; SM-88 COMPONENT SIROLIMUS; HMS2089A21; HMS3403F11; EX-A1044; Tox21_110870; Tox21_112750; AC-722; BDBM50064359; MFCD00867594; STL570275; AKOS015850976; AKOS015961618; ZINC169289388; ACN-035837; CCG-100684; CS-0063; DB00877; NCGC00021305-06; NCGC00021305-07; Rapamycin from Streptomyces hygroscopicus; AS-11687; HY-10219; SMR004701276; LS-143290; UNM-0000358684; A-275; FT-0082351; R0097; Rapamycin, VETRANAL(TM), analytical standard; EC 610-965-5; Q32089; S-7759; 123R889; Q-201659; BRD-K84937637-001-04-0; BRD-K84937637-001-06-5; BRD-K89626439-001-01-0; 24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypy; Rapamycin from Streptomyces hygroscopicus, >=95% (HPLC), powder; Rapamycin from Streptomyces hygroscopicus, Vetec(TM) reagent grade, >=95%; Sirolimus solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material; (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34 aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hex adecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydro xy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy- 6,8,12,14,20,26-hexamethyl-23,27-ep; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-4,9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-223,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(6H,31H)-pentone; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-(methyloxy)cyclohexyl]-1-methylethyl}-6,8,12,14,20,26-hexamethyl-10,21-bis(methyloxy)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,; 1,18-Dihydroxy-12-[2-(4-hydroxy-3-methoxy-cyclohexyl)-1-methyl-ethyl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-aza-tricyclo[30.3.1.0*4,9*]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone (Rapamycin); Sirolimus; Antibiotic AY 22989
Sitagliptin (3R)-3-Amino-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-1-butanone; Sitagliptin; HSDB 7516
Sobetirome 2-[4-[[4-Hydroxy-3-(1-methylethyl)phenyl]methyl]-3,5-dimethylphenoxy]acetic acid; Sobetirome; UNII-XQ31741E9Q